FORTE BIOSCIENCES ($FBRX) posted quarterly earnings results for Q2 2026 on Wednesday, August 12th. The company reported earnings of -$0.97 per share, missing estimates of -$0.90 by $0.07. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $FBRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FORTE BIOSCIENCES Hedge Fund Activity
We have seen 48 institutional investors add shares of FORTE BIOSCIENCES stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,156,941 shares (+1755.0%) to their portfolio in Q2 2026, for an estimated $24,584,996
- MPM BIOIMPACT LLC added 1,000,682 shares (+inf%) to their portfolio in Q1 2026, for an estimated $25,917,663
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 616,667 shares (+185.0%) to their portfolio in Q1 2026, for an estimated $15,971,675
- POINT72 ASSET MANAGEMENT, L.P. removed 487,275 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,620,422
- MORGAN STANLEY added 429,767 shares (+609.3%) to their portfolio in Q1 2026, for an estimated $11,130,965
- GEODE CAPITAL MANAGEMENT, LLC added 347,838 shares (+277.3%) to their portfolio in Q2 2026, for an estimated $7,391,557
- FEDERATED HERMES, INC. added 345,000 shares (+19.5%) to their portfolio in Q2 2026, for an estimated $7,331,250
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
